Exemestane or Docetaxel-Cytoxan in Low Recurrence Score Cancers
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The patients are being asked to take part in this study because they have a hormone
receptor-positive breast cancer (contains estrogen and/or progesterone receptors) and their
doctor has told them that they have an option to receive chemotherapy or hormonal therapy
before surgery. The purpose of this study is to assess if chemotherapy using docetaxel and
cytoxan (TC) or hormonal therapy using exemestane can shrink the size of their breast tumor
and allow them to preserve the breast or have less extensive surgery on their breast.